Stanley Ly

Family Medicine

809 Gallagher Dr Ste D
Sherman, TX 75090

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.

TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.

Journal: Leukemia

Published: August 17, 2023

Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.

Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.

Journal: Blood

Published: November 03, 2021

Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer.

Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer.

Journal: British journal of cancer

Published: April 14, 2021

Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells.

Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells.

Journal: Journal for immunotherapy of cancer

Published: January 26, 2021

Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.

Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.

Journal: PloS one

Published: September 15, 2020

Showing 1-5 of 5

Last Updated: 09/26/2026